A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The company says its new drug in pill form is as safe and effective as Ozempic and other popular injectables for weight loss ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Fact checked by Nick Blackmer More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Some people with type 1 say these drugs have been game-changers, helping them gain control of wild blood sugar swings for the ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...